The Bodyport Cardiac Scale is designed to detect signals through an individual’s feet to noninvasively measure a broad spectrum of hemodynamic biomarkers for heart function and fluid status.
Furoscix is a wearable, pre-programmed on-body furosemide delivery system for outpatient self-administration.
Pemafibrate is an investigational selective peroxisome proliferator activator receptor-alpha modulator (SPPARMα).
The VALOR-HCM trial evaluated the effects of mavacamten in over 100 patients with symptomatic obstructive HCM (NYHA class III-IV) who met the guideline criteria for SRT and had been referred for an invasive procedure.
The new formulation is expected to save preparation time.
The strength of the scientific evidence supporting the relationship will be disclosed as “supportive but inconclusive” to avoid misleading consumers.
Nitroglycerin Lingual Spray is indicated for the acute relief of an attack or prophylaxis of chest pain due to coronary artery disease in adult patients.
The designation was based on data from the phase 2 REDWOOD-HCM trial.
The meta-analysis included 69 RCTs with a total of 27,079 patients.
After his clinical privileges at the hospital were revoked, Dr S filed a lawsuit against numerous individuals involved in the peer review process.
